Physician profile
Steve D Johnson
NPI 1144338880
$16,946.08
in general payments reported to CMS, 2019-2025
51 companies · $2,604 in 2025
The $2,604 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,939 · 2020: $1,424 · 2021: $2,425 · 2022: $2,401 · 2023: $2,494 · 2024: $2,660 · 2025: $2,604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,757.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,129.65 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,541.75 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,276.03 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,140.85 | 2019-2024 | Xarelto |
| Pfizer INC. | $934.74 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $834.74 | 2019-2025 | Verquvo, Belsomra, Capvaxive |
| Novartis Pharmaceuticals Corporation | $806.74 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $798.50 | 2019-2025 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $614.65 | 2019-2025 | Jardiance |
| Mdd US Operations, LLC | $611.89 | 2022-2024 | Gocovri, Gocovri, Apokyn |
| Esperion Therapeutics, INC. | $509.23 | 2020-2024 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $500.99 | 2021-2025 | |
| Lilly USA, LLC | $491.04 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $471.86 | 2019-2025 | Xifaxan |
| Amgen INC. | $420.66 | 2019-2025 | Repatha, Krystexxa |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $344.64 | 2023-2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $306.46 | 2023-2025 | Korlym |
| Kowa Pharmaceuticals America, INC. | $250.60 | 2019-2024 | Livalo, Seglentis |
| Dexcom, INC. | $248.32 | 2021-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $219.18 | 2024 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $212.65 | 2019-2022 | |
| Amarin Pharma, INC. | $200.00 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $192.32 | 2019-2023 | Linzess |
| Astellas Pharma US INC | $190.48 | 2019-2023 | Myrbetriq, Veozah |
| Lundbeck LLC | $180.14 | 2023-2024 | Rexulti |
| Eisai INC. | $150.40 | 2020-2025 | |
| Otsuka America Pharmaceutical, INC. | $134.61 | 2025 | Rexulti |
| Radius Health, INC. | $132.94 | 2019-2021 | |
| Allergan, INC. | $124.62 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $112.02 | 2022 | |
| Indivior INC. | $90.33 | 2019-2025 | Sublocade |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $82.05 | 2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $78.59 | 2024-2025 | Voquezna |
| Antares Pharma, INC. | $73.19 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Alkermes, INC. | $66.48 | 2022-2023 | Aristada, Lybalvi |
| E.R. Squibb & Sons, L.L.C. | $63.62 | 2019-2022 | |
| Evoke Pharma, INC. | $57.44 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $56.73 | 2022 | |
| Collegium Pharmaceutical, INC. | $50.69 | 2019-2020 | |
| Boston Scientific Corporation | $33.33 | 2023-2025 | General - Pain Management |
| Hitachi Healthcare Americas Corp. | $33.32 | 2020 | |
| Scilex Pharmaceuticals INC. | $29.22 | 2022 | |
| Hikma Pharmaceuticals USA | $29.12 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $24.91 | 2024 | Nuplazid |
| Biohaven Pharmaceutical Holding Company LTD. | $15.45 | 2022 | |
| Daiichi Sankyo INC. | $15.34 | 2020 | |
| Vifor Pharma, INC. | $13.56 | 2025 | Zemaira |
| Therapeuticsmd, INC. | $12.88 | 2019 | |
| Hologic Sales and Service, LLC | $12.71 | 2019 | |
| Genentech USA, INC. | $12.49 | 2019 | |
| Glaxosmithkline, LLC. | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.